Dr. Saltarelli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13 Acacia Dr
Tiburon, CA 94920Phone+1 224-430-4681
Education & Training
- Johns Hopkins University School of MedicineClass of 1986
Certifications & Licensure
- CT State Medical License 2003 - 2019
- GA State Medical License 1993 - 2019
Publications & Presentations
PubMed
- 72 citationsA double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescentsKaren Dineen Wagner, Laura Redden, Robert A. Kowatch, Timothy E. Wilens, Scott Segal
Journal of the American Academy of Child and Adolescent Psychiatry. 2009-05-01 - 60 citationsBlockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925.Ariel Graff-Guerrero, Laura Redden, Walid M. Abi-Saab, David A. Katz, Sylvain Houle
The International Journal of Neuropsychopharmacology. 2010-04-01 - 29 citationsA Double-Blind, Randomized, Placebo-Controlled Study of the Dopamine D3 Receptor Antagonist ABT-925 in Patients With Acute SchizophreniaLaura Redden, Beatrice Rendenbach-Mueller, Walid M. Abi-Saab, David A. Katz, Armen Goenjian
Journal of Clinical Psychopharmacology. 2011-04-01
Press Mentions
- As Codiak Enters 'Next Phase of Growth,' Jennifer Wheler Steps into CMO Role; Mark Timney Lines up His Second CEO Opportunity After Purdue Pharma ReignMay 14th, 2021
- Chutes & Ladders—Gossamer Vet Salter-Cid Dons CSO Mantle at Flagship's New Pioneering Medicines UnitMay 14th, 2021
- Bioasis Announces Annual General Meeting ResultsDecember 5th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: